Literature DB >> 19605882

Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness.

Chris T Bauch1, Andrea M Anonychuk, Thierry Van Effelterre, Bá Z Pham, Maraki Fikre Merid.   

Abstract

BACKGROUND: Cohort models are often used in cost-effectiveness analysis (CEA) of vaccination. However, because they cannot capture herd immunity effects, cohort models underestimate the reduction in incidence caused by vaccination. Dynamic models capture herd immunity effects but are often not adopted in vaccine CEA.
OBJECTIVE: The objective was to develop a pseudo-dynamic approximation that can be incorporated into an existing cohort model to capture herd immunity effects.
METHODS: The authors approximated changing force of infection due to universal vaccination for a pediatric infectious disease. The projected lifetime cases in a cohort were compared under 1) a cohort model, 2) a cohort model with pseudo-dynamic approximation, and 3) an age-structured susceptible-exposed-infectious-recovered compartmental (dynamic) model. The authors extended the methodology to sexually transmitted infections.
RESULTS: For average to high values of vaccine coverage (P > 60%) and small to average values of the basic reproduction number (R(0) < 10), which describes school-based vaccination programs for many common infections, the pseudo-dynamic approximation significantly improved projected lifetime cases and was close to projections of the full dynamic model. For large values of R(0) (R(0) > 15), projected lifetime cases were similar under the dynamic model and the cohort model, both with and without pseudo-dynamic approximation. The approximation captures changes in the mean age at infection in the 1st vaccinated cohort.
CONCLUSIONS: This methodology allows for preliminary assessment of herd immunity effects on CEA of universal vaccination for pediatric infectious diseases. The method requires simple adjustments to an existing cohort model and less data than a full dynamic model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605882     DOI: 10.1177/0272989X09334419

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  15 in total

Review 1.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 2.  A review of the cost-effectiveness of adult influenza vaccination and other preventive services.

Authors:  Nazila M Dabestani; Andrew J Leidner; Eric E Seiber; Hyoshin Kim; Samuel B Graitcer; Ivo M Foppa; Carolyn B Bridges
Journal:  Prev Med       Date:  2019-05-29       Impact factor: 4.018

3.  Too much of a good thing? When to stop catch-up vaccination.

Authors:  David W Hutton; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2013-07-15       Impact factor: 2.583

4.  Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines.

Authors:  Jamison Pike; Andrew J Leidner; Harrell Chesson; Charles Stoecker; Scott D Grosse
Journal:  Appl Health Econ Health Policy       Date:  2022-02-09       Impact factor: 3.686

5.  Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.

Authors:  Greg L Plosker
Journal:  Drugs R D       Date:  2012-12-01

Review 6.  Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.

Authors:  Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2011-05       Impact factor: 4.558

7.  Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.

Authors:  Bernhard Ultsch; Oliver Damm; Philippe Beutels; Joke Bilcke; Bernd Brüggenjürgen; Andreas Gerber-Grote; Wolfgang Greiner; Germaine Hanquet; Raymond Hutubessy; Mark Jit; Mirjam Knol; Rüdiger von Kries; Alexander Kuhlmann; Daniel Levy-Bruhl; Matthias Perleth; Maarten Postma; Heini Salo; Uwe Siebert; Jürgen Wasem; Ole Wichmann
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

Review 8.  Dissecting the indirect effects caused by vaccines into the basic elements.

Authors:  Carla D Scarbrough Lefebvre; Augustin Terlinden; Baudouin Standaert
Journal:  Hum Vaccin Immunother       Date:  2015-07-17       Impact factor: 3.452

9.  A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.

Authors:  Andrea M Anonychuk; Chris T Bauch; Maraki Fikre Merid; Georges Van Kriekinge; Nadia Demarteau
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

10.  An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models.

Authors:  Ilse Van Vlaenderen; Laure-Anne Van Bellinghen; Genevieve Meier; Barbara Poulsen Nautrup
Journal:  BMC Infect Dis       Date:  2013-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.